BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34848452)

  • 21. KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.
    Feng R; Ma H; Hassig CA; Payne JE; Smith ND; Mapara MY; Hager JH; Lentzsch S
    Mol Cancer Ther; 2008 Jun; 7(6):1494-505. PubMed ID: 18566220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy of Histone-Deacetylase Inhibitor AR-42 with Cisplatin in Bladder Cancer.
    Li DR; Zhang H; Peek E; Wang S; Du L; Li G; Chin AI
    J Urol; 2015 Aug; 194(2):547-55. PubMed ID: 25748177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.
    Abaza MS; Bahman AM; Al-Attiyah RJ; Kollamparambil AM
    Tumour Biol; 2012 Dec; 33(6):1951-72. PubMed ID: 23011889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel hydroxysuberamide derivative potentiates MG132-mediated anticancer activity against human hormone refractory prostate cancers--the role of histone deacetylase and endoplasmic reticulum stress.
    Chen YC; Huang WJ; Hsu JL; Yu CC; Wang WT; Guh JH
    Prostate; 2013 Sep; 73(12):1270-80. PubMed ID: 23813634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
    PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
    Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.
    Zhang QL; Wang L; Zhang YW; Jiang XX; Yang F; Wu WL; Janin A; Chen Z; Shen ZX; Chen SJ; Zhao WL
    Leukemia; 2009 Aug; 23(8):1507-14. PubMed ID: 19282831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation.
    Pang XL; He G; Liu YB; Wang Y; Zhang B
    World J Gastroenterol; 2013 Mar; 19(11):1736-48. PubMed ID: 23555162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo selective antitumor activity of a novel orally bioavailable proteasome inhibitor MLN9708 against multiple myeloma cells.
    Chauhan D; Tian Z; Zhou B; Kuhn D; Orlowski R; Raje N; Richardson P; Anderson KC
    Clin Cancer Res; 2011 Aug; 17(16):5311-21. PubMed ID: 21724551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.
    Kikuchi S; Suzuki R; Ohguchi H; Yoshida Y; Lu D; Cottini F; Jakubikova J; Bianchi G; Harada T; Gorgun G; Tai YT; Richardson PG; Hideshima T; Anderson KC
    Leukemia; 2015 Sep; 29(9):1918-27. PubMed ID: 25801913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin-proteasome System Is a Promising Target for Killing Cisplatin-resistant Bladder Cancer Cells.
    Okubo K; Isono M; Asano T; REßING N; Schulz WA; Hansen FK; Sato A
    Anticancer Res; 2021 Jun; 41(6):2901-2912. PubMed ID: 34083281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells.
    Li X; Zhu F; Jiang J; Sun C; Zhong Q; Shen M; Wang X; Tian R; Shi C; Xu M; Peng F; Guo X; Hu J; Ye D; Wang M; Qin R
    Autophagy; 2016 Sep; 12(9):1521-37. PubMed ID: 27308733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin-romidepsin combination kills bladder cancer cells synergistically.
    Okubo K; Miyai K; Kato K; Asano T; Sato A
    Transl Oncol; 2021 Sep; 14(9):101154. PubMed ID: 34144348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-inhibition of BET and proteasome enhances ER stress and Bim-dependent apoptosis with augmented cancer therapeutic efficacy.
    Qian G; Yao W; Zhang S; Bajpai R; Hall WD; Shanmugam M; Lonial S; Sun SY
    Cancer Lett; 2018 Oct; 435():44-54. PubMed ID: 30059709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
    Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells.
    Xu Y; Li D; Zeng L; Wang C; Zhang L; Wang Y; Yu Y; Liu S; Li Z
    Mol Med Rep; 2015 Jan; 11(1):189-95. PubMed ID: 25323748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoplasmic reticulum stress leads to mitochondria-mediated apoptosis in cells treated with anti-HIV protease inhibitor ritonavir.
    Ganta KK; Chaubey B
    Cell Biol Toxicol; 2019 Jun; 35(3):189-204. PubMed ID: 30386960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.
    Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y
    Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine.
    Cosenza M; Civallero M; Marcheselli L; Sacchi S; Pozzi S
    Apoptosis; 2017 Jun; 22(6):827-840. PubMed ID: 28315173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.